Meibomian Gland Dysfunction Management

Running, not enrolling · Not applicable

Conditions studied: Contact Lens Discomfort, Meibomian Gland Dysfunction

In brief

The purpose of this study is to compare electronic debridement of the eyelid margin (BlephEx) to manual debridement of the eyelid margin as treatment options for patients intolerant to contact lens wear consequent to Meibomian gland dysfunction.

Key facts

Study ID

NCT03652337

Run by

University of the Incarnate Word

People needed

60

Starts

2018-05-10

Expected to finish

2019-04-10

Last updated by the study team

2018-09-05

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Habitual contact lens wearers whose contact lens wear time has reduced due to MGD will be preferentially considered for this study. Subjects who currently cannot wear contact lenses due to MGD may be considered on a case-by-case basis.

You may not qualify if…

• Subjects who are currently using any prescription ophthalmic medications (such as antibiotics, steroids and immunomodulatory drugs) will be excluded from participation.
• Subjects who have active ocular infections will be excluded from participation.

Where it is running

• Rosenberg School of Optometry — San Antonio, Texas, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.